Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pain Management Drugs Market , 2021-2027

  • GEN4646469
  • 94 Pages
  • June 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global pain management drugs market is projected to grow at a compound annual growth rate (CAGR) of 4.56% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global pain management drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The pain management drugs market is segmented on the basis of drug class, and indication, and region. The pain management drugs market is segmented as below:

By Drug Class:

- anesthetics

- anticonvulsant

- antidepressant drugs

- antimigraine drug

- non-narcotic analgesics

- NSAIDS

- opioids

By Indication:

- arthritic pain

- cancer pain

- chronic pain

- fibromyalgia

- migraine

- neuropathic pain

- post-operative pain

By Region:

- region

- Asia-Pacific

- Europe

- North America

- Middle East and Africa (MEA)

- South America

The market research report covers the analysis of key stake holders of the pain management drugs market. Some of the leading players profiled in the report include Abbott Laboratories, Eli Lily and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Mylan N.V, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., among others.

*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

- To analyze and forecast the market size of the global pain management drugs market.

- To classify and forecast the global pain management drugs market based on drug class, and indication, and region.

- To identify drivers and challenges for the global pain management drugs market.

- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pain management drugs market.

- To conduct pricing analysis for the global pain management drugs market.

- To identify and analyze the profile of leading players operating in the global pain management drugs market.

Why Choose This Report

- Gain a reliable outlook of the global pain management drugs market forecasts from 2021 to 2027 across scenarios.

- Identify growth segments for investment.

- Stay ahead of competitors through company profiles and market data.

- The market estimate for ease of analysis across scenarios in Excel format.

- Strategy consulting and research support for three months.

- Print authentication provided for the single-user license.

Part 1. Introduction

1.1 Market Definition

1.2 Key Benefit

1.3 Market Segment

Part 2. Methodology

2.1 Primary

2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

4.1 Introduction

4.2 Market Size and Forecast

4.3 Market Dynamics

4.3.1 Drivers

4.3.2 Restraints

4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Pain Management Drugs by Drug Class

5.1 Anesthetics

5.1.1 Market Size and Forecast

5.2 Anticonvulsant

5.2.1 Market Size and Forecast

5.3 Antidepressant Drugs

5.3.1 Market Size and Forecast

5.4 Antimigraine Drug

5.4.1 Market Size and Forecast

5.5 Non-Narcotic Analgesics

5.5.1 Market Size and Forecast

5.6 Nsaids

5.6.1 Market Size and Forecast

5.7 Opioids

5.7.1 Market Size and Forecast

Part 6. Global Market for Pain Management Drugs by Indication

6.1 Arthritic Pain

6.1.1 Market Size and Forecast

6.2 Cancer Pain

6.2.1 Market Size and Forecast

6.3 Chronic Pain

6.3.1 Market Size and Forecast

6.4 Fibromyalgia

6.4.1 Market Size and Forecast

6.5 Migraine

6.5.1 Market Size and Forecast

6.6 Neuropathic Pain

6.6.1 Market Size and Forecast

6.7 Post-Operative Pain

6.7.1 Market Size and Forecast

Part 8. Global Market for Pain Management Drugs by Region

8.1 Asia-Pacific

8.1.1 Market Size and Forecast

8.2 Europe

8.2.1 Market Size and Forecast

8.3 North America

8.3.1 Market Size and Forecast

8.4 Middle East And Africa (Mea)

8.4.1 Market Size and Forecast

8.5 South America

8.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles

8.1 Abbott Laboratories

8.2 Eli Lily and Company

8.3 GlaxoSmithKline plc

8.4 Johnson & Johnson

8.5 Merck & Co.

8.6 Mylan N.V

8.7 Novartis International AG

8.8 Pfizer Inc.

8.9 Purdue Pharma L.P.

*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis

9.1 Patent Statistics

9.2 Regional Analysis

9.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390